v3.25.2
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total The Cannabist Company Holdings Inc. Shareholders' Equity
Common Shares
Proportionate Voting Shares
Additional Paid-in Capital
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2023     420,265,306 9,807,881      
Beginning balance at Dec. 31, 2023 $ 65,352 $ 66,872     $ 1,146,154 $ (1,079,282) $ (1,520)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation [1] 3,182 3,182     3,182    
Conversion of convertible notes (in shares)     25,845,259        
Conversion of convertible notes 10,000 10,000     10,000    
Conversion between classes of shares (in shares)     2,106,055 (2,106,055)      
Deconsolidation of subsidiary (1,058) (1,058)       (1,058)  
Net loss (34,568) (35,073)       (35,073) 505
Ending balance (in shares) at Mar. 31, 2024     448,216,620 7,701,826      
Ending balance at Mar. 31, 2024 42,908 43,923     1,159,336 (1,115,413) (1,015)
Beginning balance (in shares) at Dec. 31, 2023     420,265,306 9,807,881      
Beginning balance at Dec. 31, 2023 65,352 66,872     1,146,154 (1,079,282) (1,520)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (48,211)            
Ending balance (in shares) at Jun. 30, 2024     461,943,098 7,701,826      
Ending balance at Jun. 30, 2024 23,384 23,701     1,152,757 (1,129,056) (317)
Beginning balance (in shares) at Mar. 31, 2024     448,216,620 7,701,826      
Beginning balance at Mar. 31, 2024 42,908 43,923     1,159,336 (1,115,413) (1,015)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation (in shares) [1]     8,225,383        
Equity-based compensation [1] (9,399) (9,399)     (9,399)    
Conversion of convertible notes (in shares)     655,736        
Conversion of convertible notes 200 200     200    
Legal settlement (in shares)     4,845,359        
Legal settlement 2,620 2,620     2,620    
Deconsolidation of subsidiary 1,031 1,031       1,031  
Distributions (333) (333)       (333)  
Net loss (13,643) (14,341)       (14,341) 698
Ending balance (in shares) at Jun. 30, 2024     461,943,098 7,701,826      
Ending balance at Jun. 30, 2024 23,384 23,701     1,152,757 (1,129,056) (317)
Beginning balance (in shares) at Dec. 31, 2024     465,638,304 7,387,328      
Beginning balance at Dec. 31, 2024 (30,059) (28,694)     1,156,807 (1,185,501) (1,365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation (in shares) [1]     93,662        
Equity-based compensation [1] 292 292     292    
Net loss (32,206) (32,204)       (32,204) (2)
Ending balance (in shares) at Mar. 31, 2025     465,544,642 7,387,328      
Ending balance at Mar. 31, 2025 (61,973) (60,606)     1,157,099 (1,217,705) (1,367)
Beginning balance (in shares) at Dec. 31, 2024     465,638,304 7,387,328      
Beginning balance at Dec. 31, 2024 (30,059) (28,694)     1,156,807 (1,185,501) (1,365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (109,592)            
Ending balance (in shares) at Jun. 30, 2025     491,745,341 7,387,328      
Ending balance at Jun. 30, 2025 (138,846) (137,974)     1,157,612 (1,295,586) (872)
Beginning balance (in shares) at Mar. 31, 2025     465,544,642 7,387,328      
Beginning balance at Mar. 31, 2025 (61,973) (60,606)     1,157,099 (1,217,705) (1,367)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation [1] 525 525     525    
Distributions         (12)    
Distributions (12) (12)          
Net loss (77,386) (77,881)       (77,881) 495
Ending balance (in shares) at Jun. 30, 2025     491,745,341 7,387,328      
Ending balance at Jun. 30, 2025 $ (138,846) $ (137,974)     $ 1,157,612 $ (1,295,586) $ (872)
[1] (1) The amount shown are net of any shares withheld by the Company to satisfy certain tax withholdings in connection with vesting of equity-based awards.